Satisfaction with treatment doesn’t necessarily affect whether people with myasthenia gravis (MG) take their medications as directed, according to a…
Articles by Marisa Horak, MS
Researchers called for standardized guidelines for diagnosing and treating people with myasthenia gravis (MG) who test negative for typical…
Most neurologists believe that CAR T-cell treatments have the potential to revolutionize care for neuro-immune diseases such as myasthenia…
Myasthenia gravis (MG) can have a substantial impact on a person’s quality of life, but currently available data make…
Myasthenia gravis (MG) may be driven by antibody-producing immune B-cells going rogue in the thymus gland and developing escape…
Vyvgart (efgartigimod alfa-fcab), an approved treatment for myasthenia gravis (MG), can quickly and safely ease symptoms in people…
Top-line results — a snapshot of key early findings — from a large international clinical trial testing Immunovant’s therapy…
TPST-4003, Tempest Therapeutics’ next-generation CAR T-cell therapy for autoimmune diseases such as myasthenia gravis (MG), will soon be…
To successfully navigate life with myasthenia gravis (MG), people need to be aware of their own bodies and limitations,…
The Muscular Dystrophy Association (MDA) is hosting a series of four free, in-person educational events across the U.S. to support…